Funding News

IHH Healthcare Is Doubling Down on India: 2,000 New Beds by 2028 and a Push to Increase Its Fortis Stake to 50%

By Mustafa Shariff, Editor in Chief · April 13, 2026 · 5 min read

Mustafa Shariff, Editor in Chief — IHH Healthcare Is Doubling Down on India: 2,000 New Beds by 2028 and a Push to Increase Its Fortis Stake to 50%

Summary

  • IHH Healthcare's India Expansion: 2,000 New Beds by 2028, ₹2,500 Crore Capex, and the Push to Control Fortis at 50%
  • IHH Healthcare has resolved its seven-year SEBI open offer dispute and is moving into India's next phase of growth. Here is the full expansion plan and what it means for the Indian hospital sector.

IHH Healthcare — Asia's largest multinational private healthcare provider, listed in Malaysia and Singapore — has waited seven years to move decisively in India. After a protracted legal dispute that froze its mandatory open offer obligation in Fortis Healthcare since 2018, the SEBI clearance is finally in place. And IHH is not wasting a moment.

The group has announced plans to add 2,000 new hospital beds across India by 2028 — a 40% increase from its current combined network of approximately 5,000 beds across 35 hospitals in 11 states, operated through the Fortis Healthcare and Gleneagles Hospital brands. The bed addition will come through a combination of brownfield expansion in existing facilities and targeted greenfield hospital development. IHH has committed ₹2,500 crore in capital expenditure over the next three years to fund this expansion, with an ambition of reaching 10,000 operational beds in India by 2030.

The Seven-Year Backstory

Understanding IHH's current India moment requires understanding the extraordinary regulatory and legal odyssey that preceded it. IHH acquired a 31% stake in Fortis Healthcare through its subsidiary NTK in November 2018, triggering a mandatory open offer obligation under SEBI's takeover code to acquire an additional 26% from public shareholders. That open offer was immediately caught in a legal standoff — Japanese pharmaceutical company Daiichi Sankyo had filed a contempt petition against Fortis founders Malvinder and Shivinder Singh over their earlier sale of Ranbaxy Laboratories, and the courts froze corporate actions at Fortis while the dispute wound its way through multiple legal forums.

The dispute resolution took until late 2025, when SEBI finally approved IHH's open offer. The completed offer now positions IHH as a controlling shareholder in Fortis with a pathway to increasing its stake toward 50% — the medium-term ownership target that IHH's group CEO Prem Kumar Nair has articulated publicly.

What IHH Brings to the Indian Market

IHH is not just a financial investor in Fortis — it is an operator with deep clinical and operational expertise across Asia. The group manages hospitals in Malaysia, Singapore, Turkey, China, India, and several other markets, serving patients across a spectrum from primary care to complex quaternary interventions. Its clinical quality systems, international accreditation frameworks, and operational management processes represent genuine capability that can strengthen Fortis's clinical performance.

The Fortis network — 33 healthcare facilities including joint ventures and operations-and-maintenance facilities, with approximately 5,800 operational beds — is concentrated in north India with strengths in Delhi-NCR, Punjab, and Haryana, and selected presence in other major cities. Over the past three years, Fortis has added over 1,800 beds primarily through brownfield capacity expansion within existing facilities. The 2,000-bed addition by 2028 represents a significant acceleration of this pace.

The Competitive Dynamics

IHH's expansion creates additional pressure on India's existing large hospital groups. Apollo Hospitals, currently India's largest by bed count with 73 hospitals and over 8,000 operational beds, is simultaneously executing its own aggressive expansion. Max Healthcare is adding eastern India to its geographic footprint through the Kalinga Hospital acquisition. Manipal, post its Sahyadri acquisition, is the widest-footprint chain by number of hospitals. And Narayana Health has now expanded internationally into the UK.

India's hospital sector is simultaneously executing the most ambitious capacity expansion it has ever attempted — with leading chains collectively planning to add over 18,000 beds in the next three to five years, according to EY-Parthenon data. The constraint is not capital or ambition — it is clinical talent. The simultaneous expansion of Apollo, Max, IHH-Fortis, Manipal, and Narayana creates unprecedented demand for hospital administrators, department heads, nursing leaders, and allied health professionals at a scale India's healthcare education system is not currently producing.

BHC Perspective

At Bengaluru Health Community, IHH's India expansion is a signal that the global hospital investment community views India as one of the world's two or three most important healthcare markets for the next decade. The fact that Asia's largest hospital group has committed ₹2,500 crore to Indian capacity expansion after resolving its regulatory standoff reinforces what Indian healthcare founders, investors, and clinicians already know: the demand side of this market is structurally compelling and long-duration. The supply side — clinical talent, quality management systems, and technology — is where the real competitive differentiation will be built.

Frequently Asked Questions

Q: What is IHH Healthcare's India expansion plan?
A: IHH Healthcare plans to add 2,000 new hospital beds across India by 2028, invest ₹2,500 crore in capital expenditure over three years, and increase its stake in Fortis Healthcare from 31% toward a 50% target, aiming for 10,000 total Indian beds by 2030.

Q: Why did IHH's Fortis deal take seven years to fully resolve?
A: IHH acquired a 31% Fortis stake in November 2018, triggering a mandatory open offer obligation. The offer was frozen in court proceedings linked to a dispute between Fortis founders Malvinder and Shivinder Singh and Japanese pharma company Daiichi Sankyo over the earlier Ranbaxy sale. SEBI approval finally came in late 2025.

Q: How large is the IHH-Fortis network in India?
A: The combined IHH-Fortis network currently operates 35 hospitals across 11 states with approximately 5,000-5,800 operational beds, concentrated in north India including Delhi-NCR, Punjab, and Haryana, with presence across multiple other major cities.